Birzeit Pharmaceutical Company (BPC)

Birzeit Pharmaceutical Company (BPC) is Palestine's leading manufacturer of generic medicines. The company has a broad portfolio of over 300 products across ten production lines, catering to various therapeutic ranges. BPC serves a diverse customer base in the local Palestinian market, including the Ministry of Health, local and international healthcare organizations, and end users through pharmacies and physicians. Furthermore, BPC has a strong presence in key export markets such as Algeria and East Europe, with continuous efforts to expand into new markets.

To uphold its success, BPC focuses on several key factors. These include maintaining the latest quality standards certifications such as cGMP and ISO, a robust financial position, a highly educated and well-trained staff, a credible and experienced management team, strategic investments and alliances, ongoing product and market development initiatives, modern facilities spanning 16,000 square meters, state-of-the-art production lines, and approved suppliers of raw and packaging materials.

Founded in 1937, BPC operates in the Health Care, Manufacturing, and Pharmaceutical industries. While specific headquarters and last investment details are not provided, the company's strong market presence and comprehensive approach to quality and innovation make it an intriguing prospect for potential investors seeking opportunities in the pharmaceutical sector.